What is the Open Surgery Heart Valves market size?

The Open Surgery Heart Valves market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Open Surgery Heart Valves market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Open Surgery Heart Valves market?

Key drivers include rising cardiovascular disease prevalence and technological advancements in surgical procedures.

What challenges does the Open Surgery Heart Valves market face?

Challenges include high procedure costs and risks associated with open surgery, limiting market growth.

Which regions are the leaders in the Open Surgery Heart Valves market?

North America and Europe are the leading regions, driven by well-established healthcare infrastructure.

Who are the top companies in the Open Surgery Heart Valves market?

Top companies include Medtronic, Edwards Lifesciences, and Abbott, offering a range of heart valve products.

What future opportunities exist in the Open Surgery Heart Valves market?

Future opportunities include emerging markets and advancements in minimally invasive surgical procedures.

How will technology impact the Open Surgery Heart Valves market?

Technological advancements will improve procedure outcomes, driving market growth and future outlook.

What is the regulatory landscape for the Open Surgery Heart Valves market?

The regulatory landscape is stringent, with FDA and CE mark approvals required for product commercialization.

What is the expected future outlook for the Open Surgery Heart Valves market?

The future outlook is positive, driven by increasing demand and technological advancements in surgical procedures.

Open Surgery Heart Valves Market Potential & Strategic Outlook 2033

Open Surgery Heart Valves by Application (Hospital, Clinic, Others), by Types (Mechanical Valves, TAVR), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Open Surgery Heart Valves Market Size | CAGR 4.1 Forecast 2033

Open Surgery Heart Valves Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Open Surgery Heart Valves Market Overview

The Open Surgery Heart Valves market refers to the global marketplace for surgical procedures and devices used to treat heart valve disorders. As the Open Surgery Heart Valves market size is expected to reach $4.8 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by an increasing prevalence of heart valve diseases and advancements in surgical techniques. The market forecast suggests a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033, with key drivers including technology shifts, regulations, and consumer behavior. The largest region in the Open Surgery Heart Valves market is North America, while the fastest-growing region is expected to be the Asia-Pacific.

Loading chart…

The Open Surgery Heart Valves market is shaped by several key forces, including technological advancements in surgical procedures and device development, regulatory requirements for device approval and reimbursement, and competitive intensity among market players. The industry is also influenced by supply-chain dynamics, with manufacturers and distributors playing a crucial role in ensuring the availability of high-quality devices. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest trends and developments to remain competitive. With the largest region being North America and the fastest-growing region being the Asia-Pacific, market players must be prepared to adapt to changing market conditions and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	11.31 million
Growth rate	CAGR of 4.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Vascular Inc.; Arterius Ltd; Cardionovum GmbH; Aneuclose LLC; InspireMD, Inc; Tepha, Inc.; Boston Scientific Corporation; Japan Stent Technology Co., Ltd.; Gaudi Vascular, Inc.; MicroVention, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Open Surgery Heart Valves market is poised for significant growth, driven by factors such as the increasing prevalence of heart valve diseases and advancements in surgical techniques. This section provides an overview of the market dynamics, including growth drivers, restraints, opportunities, and challenges, to help executives and strategy leaders navigate the Open Surgery Heart Valves market size and growth forecast.

Growth Drivers2 items

Advances in minimally invasive surgical techniques are expanding the patient pool for open surgery heart valves, driving growth in the Open Surgery Heart Valves market size

The rising aging population is contributing to an increased incidence of heart valve diseases, further fueling the growth forecast of the Open Surgery Heart Valves market

Restraints2 items

High procedure costs and limited reimbursement options are constraining the adoption of open surgery heart valves, impacting the Open Surgery Heart Valves market size

The availability of alternative treatment options, such as transcatheter aortic valve replacement, is also hindering the growth of the Open Surgery Heart Valves market

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present significant opportunities for growth, driven by increasing healthcare expenditure and improving infrastructure, which is expected to contribute to the Open Surgery Heart Valves market size

The development of innovative valve designs and biomaterials is expected to enhance the efficacy and durability of open surgery heart valves, supporting the growth forecast of the Open Surgery Heart Valves market

Challenges2 items

The Open Surgery Heart Valves market faces challenges related to regulatory requirements, including stringent approval processes and post-market surveillance, which can impact the growth of the Open Surgery Heart Valves market size

The need for skilled healthcare professionals and specialized training programs is a significant challenge, as it can limit the adoption of open surgery heart valves and affect the overall Open Surgery Heart Valves market growth forecast

Market Segmentation

Loading chart…

The Open Surgery Heart Valves market can be segmented based on Application, which refers to the specific use case or purpose for which the heart valves are utilized. This segmentation category contributes significantly to the overall Open Surgery Heart Valves market size, as different applications have varying demands and requirements. Understanding the application segmentation is crucial for market players to tailor their products and services to meet the needs of specific patient groups, ultimately driving business growth. The Open Surgery Heart Valves segmentation by application includes subtypes such as [object Object],[object Object], which are critical in determining the market size and trends.

Another key segmentation category in the Open Surgery Heart Valves market is Types, which encompasses various subtypes such as [object Object],[object Object]. This segmentation category plays a vital role in shaping the market landscape, as different types of heart valves have distinct characteristics, advantages, and limitations. By analyzing the types segmentation, market players can identify areas of opportunity and develop targeted strategies to enhance their market presence. The types segmentation also influences the overall market size, as different types of heart valves have varying market shares and growth prospects. Understanding the market taxonomy and Open Surgery Heart Valves segmentation by types is essential for businesses to make informed decisions and stay competitive in the market.

Open Surgery Heart Valves Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Mechanical Valves

TAVR

Regional Insights

Loading chart…

The Open Surgery Heart Valves market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and a well-established infrastructure. In Europe, drivers comprise a strong regulatory framework, rising demographics demand, and a growing ecosystem maturity. Asia Pacific is driven by rapid infrastructure development, increasing adoption of innovative technologies, and favorable policies. Latin America and Middle East & Africa are expected to be driven by improving infrastructure, rising demographics demand, and growing ecosystem awareness.

The regional forecast indicates that North America will continue to dominate the market, while Asia Pacific will experience the highest growth rate. Latin America and Middle East & Africa will also witness significant growth, driven by increasing investments in healthcare and rising demographics demand. As the Open Surgery Heart Valves market continues to evolve, understanding regional trends and drivers will be crucial for stakeholders to make informed decisions and capitalize on emerging opportunities.

Competitive Landscape

The Open Surgery Heart Valves market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Open Surgery Heart Valves competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies rely on regional distribution networks and competitive pricing.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to these challenges and focus on strategic areas such as regional expansion, innovation, and customer service.

Abbott Vascular Inc. focuses on innovation pipeline

Arterius Ltd prioritizes regional expansion

Cardionovum GmbH emphasizes local manufacturing

Aneuclose LLC pursues OEM tie-ups

InspireMD, Inc. concentrates on premium pricing

Tepha, Inc. invests in vertical integration

Key Open Surgery Heart Valves Companies10 items

Abbott Vascular Inc.

Arterius Ltd

Cardionovum GmbH

Aneuclose LLC

InspireMD, Inc

Tepha, Inc.

Boston Scientific Corporation

Japan Stent Technology Co., Ltd.

Gaudi Vascular, Inc.

MicroVention, Inc.

Market Ecosystem

The Open Surgery Heart Valves ecosystem spans across upstream, midstream, and downstream segments, involving various participants that create and capture value. It encompasses technology providers and suppliers at the upstream end, integrators and manufacturers in the midstream, and channels, end users, and service providers downstream. Understanding this ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material/component suppliers — provide valve components

OEMs / manufacturers — produce heart valves

System integrators / EPCs — integrate valve systems

Distributors / channel partners — distribute valves to hospitals

Service providers / after-sales — offer maintenance and support

End users / buyers — purchase and use heart valves

Regulators/standards bodies — set industry standards and regulations

In the Open Surgery Heart Valves ecosystem, control points are primarily held by regulators and end users, as they influence adoption through approval processes and purchasing decisions. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals. Switching costs are significant due to the high specificity of valve systems, leading to strong partnerships between suppliers and end users. The ecosystem's structure and dynamics can differ by region, with varying regulatory requirements and market conditions influencing the flow of value.

Recent Industry Insights

The Open Surgery Heart Valves industry has witnessed significant developments over the last 12-18 months, shaping the future of Open Surgery Heart Valves industry trends. Recent partnerships between major players have focused on enhancing product portfolios and expanding geographical reach. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the market. Furthermore, several product and technology launches have been announced, emphasizing advancements in minimally invasive procedures and improved valve materials.

Additionally, regulatory changes have influenced the industry, with updated guidelines for clinical trials and device approvals. A shift in consumer trends towards more personalized and minimally invasive treatments has also been observed, driving innovation in the Open Surgery Heart Valves market. Funding rounds and expansions have supported the growth of emerging companies, contributing to the industry's evolution and indicating a promising outlook for Open Surgery Heart Valves industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Open Surgery Heart Valves market outlook. The market exhibits a moderate level of attractiveness, driven by the increasing prevalence of heart valve disorders and advancements in surgical techniques. The competitive intensity is high, with key players investing heavily in research and development to improve product portfolios and expand their market share.

The long-term outlook for the Open Surgery Heart Valves market is promising, with opportunities for growth in emerging economies and the development of innovative products. However, the market is not without risks, including regulatory challenges, fluctuating demand, and supply chain disruptions. The demand–supply balance is expected to remain stable, with manufacturers working to meet the growing demand for open surgery heart valves. Key risk factors include intense competition and technological advancements that may impact market dynamics.

11 items

1. Executive Summary

2. Open Surgery Heart Valves Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Open Surgery Heart Valves Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Open Surgery Heart Valves Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Open Surgery Heart Valves Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Mechanical Valves

6.2.2. TAVR

6.3. Global Open Surgery Heart Valves Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Open Surgery Heart Valves Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Open Surgery Heart Valves Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Open Surgery Heart Valves Market Competition by Key Manufacturers

8.1. Global Open Surgery Heart Valves Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Open Surgery Heart Valves: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Vascular Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Arterius Ltd

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cardionovum GmbH

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Aneuclose LLC

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. InspireMD, Inc

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Tepha, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Boston Scientific Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Japan Stent Technology Co., Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Gaudi Vascular, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. MicroVention, Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Open Surgery Heart Valves Market

Figure 4: Global Open Surgery Heart Valves Market: Drivers

Figure 5: Global Open Surgery Heart Valves Market: Challenges

Figure 6: Global Open Surgery Heart Valves Market: Trends

Figure 7: Global Open Surgery Heart Valves Market: Opportunity

Figure 8: Global Open Surgery Heart Valves Market: Restraint

Figure 9: Global Open Surgery Heart Valves Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Open Surgery Heart Valves Market Value (USD Million) By Region

Figure 15: Global Open Surgery Heart Valves Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Open Surgery Heart Valves Market Value (USD Million) By Region

Figure 23: Global Open Surgery Heart Valves Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Open Surgery Heart Valves Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Open Surgery Heart Valves Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Open Surgery Heart Valves Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Open Surgery Heart Valves Market Value (USD Million) By Region

Table 10: Global Open Surgery Heart Valves Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Open Surgery Heart Valves Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Open Surgery Heart Valves Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Open Surgery Heart Valves Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Vascular Inc. Basic Information And Sales Area

Table 31: Abbott Vascular Inc.. Products Portfolio

Table 32: Arterius Ltd Basic Information And Sales Area

Table 33: Arterius Ltd. Products Portfolio

Table 34: Cardionovum GmbH Basic Information And Sales Area

Table 35: Cardionovum GmbH. Products Portfolio

Table 36: Aneuclose LLC Basic Information And Sales Area

Table 37: Aneuclose LLC. Products Portfolio

Table 38: InspireMD, Inc Basic Information And Sales Area

Table 39: InspireMD, Inc. Products Portfolio

Table 40: Tepha, Inc. Basic Information And Sales Area

Table 41: Tepha, Inc.. Products Portfolio

Table 42: Boston Scientific Corporation Basic Information And Sales Area

Table 43: Boston Scientific Corporation. Products Portfolio

Table 44: Japan Stent Technology Co., Ltd. Basic Information And Sales Area

Table 45: Japan Stent Technology Co., Ltd.. Products Portfolio

Table 46: Gaudi Vascular, Inc. Basic Information And Sales Area

Table 47: Gaudi Vascular, Inc.. Products Portfolio

Table 48: MicroVention, Inc. Basic Information And Sales Area

Table 49: MicroVention, Inc.. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Open Surgery Heart Valves Market Value (USD Million) By Region

Table 55: Global Open Surgery Heart Valves Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Open Surgery Heart Valves Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	11.31 million
Growth rate	CAGR of 4.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Vascular Inc.; Arterius Ltd; Cardionovum GmbH; Aneuclose LLC; InspireMD, Inc; Tepha, Inc.; Boston Scientific Corporation; Japan Stent Technology Co., Ltd.; Gaudi Vascular, Inc.; MicroVention, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options